exceeded the morning values at almost all points of time. The mean value for the lJU-min specimen from an afternoon GTT was 34% higher than the corrcsponding specimen from a morning GTT in normal individuals.
The effect of the previous diet may he even greater. We had the opportunity of comparing two sets of GTT results for a 71-ycar-old woman who had heen admitted with anaemia, glycosuria and 'a poor dietary history' (see Tahle). The two tests were performed 3 weeks apart. The repeat test had heen suggested because of the history and because the fasting level 2 days earlier had been lJ-4 mmol/L (36'X. higher). Whereas an analytical goal of a within-laboratory, between-hatch imprecision of CY <2·2% may well he correct, in achieving this laboratories must not lose sight of the fact that pre-analytical factors can he vastly more important than analytical factors for glucose analysis in the context of an oral glucose tolerance test. The author replies as follows:
Attainment of pre-analytical goals is vital Mr Simpson appears to have misunderstood one of the educational messages of my review article, I in which it was clearly stated that 'it is vital that each laboratory develops appropriate goals for important pre-analytical factors'. In the case of glucose analyses, as mentioned in my article, international bodies have already published recommendations on the performance of oral glucose tolerance tests. 2 • 3 These recommendations, which have been brought to the attention of every clinical biochemist member of a national society of the International Federation of Clinical Chemistry, 4 state that: this test should be carried out in the morning following 3 days of unrestricted diet (3150 g carbohydrate) and activity; the subject should be fasted for at least 10 h but not more than 16 h; water is a permitted drink during the test; and the subject should be seated and not allowed to smoke. Furthermore, it is well recognised that, for diseases which may require long-term therapy, for example diabetes mellitus, hypercholesterolaemia and hypothyroidism, investigation should preferably he performed when the patient does not possess other concomitant pathology.
The tests reported above hy Mr Simpson were not carried out according to those recommendations and cannot therefore he properly interpreted because the pre-analytical factors influencing the test results have not been minimised. Furthermore, it could be cogently argued that the laboratory should not have accepted the specimens for analyses until the above criteria, including that of adequate diet. had been fulfilled and the patient correctly investigated prior to proceeding to performance of thc dynamic function test as laid down in the recommcndations."·l No lahoratory would analyse a serum sample for potassium ion concentration or activity if it was grossly haemolysed; why should glucose tolerance test specimens from incorrectly prepared patients be any more acceptable?
Mr Simpson and I agree that a test result is only as good as the specimen, The specimen is only good enough when the many pre-analytical variables that exist' arc either minimised or documented and taken into account during interpretation. Interference from heparin ... in the measurement of plasma sodium on ion selective electrodes
In their paper, Mann and Green (Ann Clin Biochem 1986; 23: 355-{)) describe an experiment in which sodium and potassium were determined in serum to which various amounts of mucus heparin were added. They state that the measured results were corrected for 'the small sodium content of the mucus heparin'. However, they do not state what strength of heparin was used ..We have previously shown that the strength of heparin has an effect on the measurement of sodium. I When plasma sodium concentration is measured by direct ISE, 50lXl IU/mL of heparin will cause a decrease and 1000 IU/mL will cause an increase in measured plasma sodium concentration. Furthermore, in other experiments we have shown t~at the measured sodium concentration of heparin is higher than expected from simple dilution and the extent of this discrepancy depends on the concentration of heparin in the sample (Matt, Shek and Swaminathan, unpublished observations). Without knowing how the measured values were corrected, it is impossible to judge their results. We have measured the volume of heparin occupying the dead space of a 2 mL syringe and found it to be 70 ul, and calculated that there could be differences of 6 mrnol/L in the plasma sodium level depending on the method of measurement. I We do not agree with their suggestion that the volume of heparin used in blood gas analysis would not interfere with sodium or potassium results by flame photometry or ISE. The practice of using 'blood gas' specimens for sodium! potassium analysis should in any case be abandoned. Thank you for the opportunity to reply to Dr Swaminathan's letter. We were interested to read Dr Swaminathan's comments and do not feel that our results disagree with his findings. The stock heparins used in our study were mucus heparin, 5000 and 1000 IUlmL, and the depression due to heparin was measured by direct comparison using the two methods.
We do not disagree with his comment about the importance of recognising dilutional errors due to liquid heparin remaining in the dead space of the syringe. Our observations were restricted to the heparin effect which would exist even if dried heparin was used. We were not addressing the dilution problem in our statement. We agree with his comment of not allowing 'blood gas' specimens to be used for sodium and potassium analysis. S W MANN,
